Search 33,000+ CME courses
Back

StatPearls, LLC

  • Adrenergic Antagonists
  • Angina Pectoris
  • Atenolol
  • Myocardial Infarction
  • Propranolol

Atenolol

Atenolol is a second-generation -1 selective adrenergic antagonist that helps lower the heart rate and blood pressure of patients while also decreasing myocardial contractility. Atenolol is approved by the U.S. Food and Drug Administration (FDA) for treating hypertension, angina pectoris, and acute myocardial infarction. Off-label uses of atenolol include the treatment of arrhythmias, migraine prophylaxis, paroxysmal supraventricular tachycardia, alcohol withdrawal, thyrotoxicosis, and prophylaxis against secondary myocardial infarction. Atenolol is an alternative to propranolol in the management of infantile hemangiomas. The mechanistic actions of atenolol are complemented by several cardiovascular drugs when managing cardiac emergencies. This activity provides a comprehensive overview of atenolol, covering its indications, mechanism of action, safe administration, adverse effects, contraindications, monitoring, and toxicity. This activity also highlights the role of an interprofessional team in treating medical conditions using atenolol. Patient outcomes are optimized when this medication is utilized by a team of primary care, emergency medicine, and consulting specialists.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 1.5 creditsAAPA Category 1 Credit™Up to 1.5 creditsAMA PRA Category 1 Credit™Up to 1.5 creditsNursingUp to 1.5 creditsPharmacyUp to 1.5 credits

MOC types

ABS — Accredited CMEUp to 1.5 pointsABPATH — Lifelong LearningUp to 1.5 pointsABA — Lifelong LearningUp to 1.5 pointsABTS — Accredited CMEUp to 1.5 pointsABIM — Medical KnowledgeUp to 1.5 pointsABS — Self-AssessmentUp to 1.5 pointsABP — Lifelong Learning and Self-AssessmentUp to 1.5 pointsABTS — Self-AssessmentUp to 1.5 points

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 13 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 1.5 credits
  • MOC · Up to 1.5 points
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left

More from StatPearls, LLC

See all

This provider’s courses closest to this one